Zoetis to Participate in the 34th Annual J.P. Morgan Healthcare Conference

FLORHAM PARK, N.J.–(BUSINESS WIRE)–Zoetis
Inc. (NYSE:ZTS) will participate in the 34th Annual J.P.
Morgan Healthcare Conference on Wednesday, Jan. 13, 2016, in San
Francisco, Calif. Juan Ramón Alaix, Chief Executive Officer, will
represent the company and respond to questions from analysts. He is
scheduled to present at 12:30 p.m. EST (9:30 a.m. PST).

Investors and other interested parties will be able to access a live
audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations.
A replay of the presentation will also be available on the Zoetis
website at the conclusion of the event.

About Zoetis

Zoetis (zô-EH-tis)
is the leading animal health company, dedicated to supporting its
customers and their businesses. Building on more than 60 years of
experience in animal health, Zoetis discovers, develops, manufactures
and markets veterinary vaccines and medicines, complemented by
diagnostic products and genetic tests and supported by a range of
services. In 2014, the company generated annual revenue of $4.8 billion.
With approximately 10,000 employees worldwide at the beginning of 2015,
Zoetis serves veterinarians, livestock producers and people who raise
and care for farm and companion animals with sales of its products in
120 countries. For more information, visit www.zoetis.com.

DISCLOSURE NOTICES

Forward-Looking Statements: This
press release contains forward-looking statements, which reflect the
current views of Zoetis with respect to business plans or prospects,
future operating or financial performance, expectations regarding
products, future use of cash and dividend payments, and other future
events. These statements are not guarantees of future performance or
actions. Forward-looking statements are subject to risks and
uncertainties. If one or more of these risks or uncertainties
materialize, or if management’s underlying assumptions prove to be
incorrect, actual results may differ materially from those contemplated
by a forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement, whether as
a result of new information, future events or otherwise. A
further list and description of risks, uncertainties and other matters
can be found in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2014, including in the sections thereof captioned
“Forward-Looking Information and Factors That May Affect Future Results”
and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and
in our Current Reports on Form 8-K. These filings and subsequent filings
are available online at www.sec.gov,
www.zoetis.com,
or on request from Zoetis.

Contacts

Zoetis Inc.
Media:
Elinore White,
1-973-443-2835 (o)
elinore.y.white@zoetis.com
Kristen
Seely, 1-973-443-2777 (o)
kristen.seely@zoetis.com
or
Investors:
John
O’Connor, 1-973-822-7088 (o)
john.oconnor@zoetis.com
Steve
Frank, 1-973-822-7141 (o)
steve.frank@zoetis.com